Exhibit 31.1

             CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRESIDENT
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PracticeXpert, Inc. (the "Company")
on Form 10-QSB for the period ending March 31, 2005 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Jonathan Doctor,
Chief Executive Officer and President of the Company, certify, pursuant to Rules
13a-14 and 15-d14 of the Securities Exchange Act of 1934 (the "Exchange Act"),
as adopted pursuant to ss.302 of the Sarbanes-Oxley Act of 2002, that: 1. I have
reviewed this Report;

2. Based on my knowledge, this Report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this Report;

3. Based on my knowledge, the financial statements, and other financial
information included in this Report, fairly present in all material respects the
financial condition, results of operations and cash flows of the Company, as of,
and for, the periods presented in this Report;

4. I and the other certifying officers of the Company are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the Company, including any consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this Report is being prepared;

(b) Evaluated the effectiveness of the Company's disclosure controls and
procedures and presented in this Report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this Report based on such evaluation; and

(c) Disclosed in this Report any change in the Company's internal control over
financial reporting that occurred during the Company's most recent fiscal
quarter (the Company's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
Company's internal control over financial reporting; and

5. I and the other certifying officers have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Company's
auditors and to the audit committee of the Company's board of directors (or
persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the Company's ability to record, process, summarize
and report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the Company's internal control over
financial reporting.





                            /s/ Jonathan Doctor
                            -------------------
                            Jonathan Doctor,
                            Chief Executive Officer and President
                            May 2, 2006